An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
/in Breast Cancer, International Publications /von 2007-09-05 / Cancer Immunol. Immunother. 2008 May;57(5):611-22Comparison of intratumor and intraluminal temperatures during locoregional deep hyperthermia of pelvic tumors
/in Cervical Cancer, International Publications /von 2007-09-01 / Strahlenther Onkol 2007 Sep;183(9):479-86Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile
/in Chronic Virus Hepatitis, International Publications /von 2007-09-01 / Liver Int. 2007 Sep;27(7):944-53Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin
/in Colorectal Cancer, Hyperthermia, International Publications /von 2007-09-01 / Int J Hyperthermia 2007 Sep;23(6):513-27Antigen crosspresentation by human plasmacytoid dendritic cells
/in HIV/AIDS, International Publications /von 2007-09-01 / Immunity 2007 Sep;27(3):481-92Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine
/in Hypernephroma, International Publications /von 2007-09-01 / J. Immunol. 2007 Sep;179(5):2860-9Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study
/in Hypernephroma, International Publications /von 2007-09-01 / Oncol. Rep. 2007 Sep;18(3):665-71Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus
/in International Publications, Newcastle Disease Virus /von 2007-09-01 / Cancer Res. 2007 Sep;67(17):8285-92Comparison of dendritic cell-mediated immune responses among canine malignant cells
/in International Publications, Malignant Lymphoma /von 2007-09-01 / J. Vet. Med. Sci. 2007 Sep;69(9):925-30IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de